Clinical Immunology

Your Long-Term Monitoring and Care Team

At a Glance

Long-term care for IRF2BP2-related immunodeficiency uses a coordinated team to monitor lung function, gastrointestinal and liver health, blood counts, immune complications, and emotional well-being. Testing is individualized to symptoms and risk.

Managing IRF2BP2-related immunodeficiency is a marathon, not a sprint. Because this condition affects multiple systems—from your lungs and gut to your blood—the goal of long-term care is “proactive surveillance.” This means looking for issues before they cause severe symptoms, rather than just reacting to problems after they start ^[1]^[2].

Your Interdisciplinary Care Team

Because no single doctor can be an expert in every part of this rare condition, you will likely need a “team of captains.”

The Immunologist (Captain): Coordinates your overall care, manages your immunoglobulin infusions, and monitors your immune cell counts ^[2].
The Pulmonologist: Focuses on lung health, watching for early signs of scarring or inflammation ^[3].
The Gastroenterologist: Monitors your gut and liver, especially since GI issues are very common with this gene ^[4].
The Genetic Counselor: Helps you and your family understand the inheritance of the IRF2BP2 variant and what it means for relatives ^[3].

Lung Health: Monitoring the Shield

Protecting your lungs is a top priority. Your team will use two main tools to watch for bronchiectasis (lung scarring) or GLILD (Granulomatous-Lymphocytic Interstitial Lung Disease, a type of immune-related lung inflammation) ^[5]^[6].

Pulmonary Function Tests (PFTs): These breathing tests may be followed periodically (often annually in higher-risk patients). They should ideally include a “diffusion capacity” (DLCO) test, which measures how well oxygen moves from your lungs into your blood ^[1]^[5].
High-Resolution CT (HRCT): A specialized scan of the lungs. Frequency is individualized; CT should generally be driven by symptoms, abnormal PFTs, suspected bronchiectasis, or specialist assessment to minimize unnecessary radiation ^[1]^[7].

Gastrointestinal and Liver Surveillance

The IRF2BP2 gene is heavily involved in gut regulation.

Endoscopy: Routine endoscopy and repeat H. pylori testing are not universal protocols for everyone with this variant; they should be based on symptoms (like persistent diarrhea, weight loss, bleeding), anemia, family history, and the clinician’s assessment ^[8]^[9].
Liver Monitoring: Regular bloodwork should include a “liver profile” and potentially an ultrasound or a specialized “elastography” (a non-invasive test for liver stiffness) if your enzymes are elevated ^[10]^[11].

Monitoring for “Friendly Fire” (Autoimmunity)

Because your immune system can sometimes attack your own body, your team will keep a close eye on your blood and lymph nodes.

Blood Counts (CBC): Regular blood tests look for cytopenias, where the body destroys its own red cells or platelets. A sudden drop in platelets can be an early sign of an overactive immune system, though cytopenias can also be infectious or medication-related ^[12]^[13].
Lymph Node Checks: At every visit, your doctor should feel for enlarged lymph nodes or a swollen spleen (splenomegaly). Do not assume swelling is benign inflammation; these findings require careful evaluation to rule out infection, lymphoproliferation, or malignancy ^[2]^[14].
Micronutrients: You should have regular checks for Vitamin B12, iron, and other nutrients, as your gut may not absorb them well ^[8]^[15].

The Emotional Weight of Monitoring

Living with a rare condition often means “scan anxiety”—the stress that builds up before a scheduled test or while waiting for results. It is normal to feel overwhelmed by the number of appointments and the unpredictability of a genetic diagnosis ^[16].

Comprehensive care should include more than just labs; it should also address your mental health. Don’t hesitate to ask for a referral to a health psychologist or social worker who understands the unique burden of living with a chronic, “invisible” illness ^[17]^[18]. Establishing a routine for your monitoring can help you feel more in control of your health journey.

Common questions in this guide

Which specialists usually care for someone with IRF2BP2-related immunodeficiency?

An immunologist usually coordinates care, while a pulmonologist monitors the lungs, a gastroenterologist monitors the gut and liver, and a genetic counselor explains inheritance. A health psychologist or social worker may also help with the emotional and practical burden of ongoing care.

How are lung complications monitored in IRF2BP2-related immunodeficiency?

Breathing tests called pulmonary function tests may be repeated periodically, often yearly for people at higher risk, and may include a diffusion-capacity test called DLCO. A high-resolution CT scan is usually considered when symptoms, abnormal breathing tests, suspected bronchiectasis, or specialist assessment make it useful.

Does everyone with IRF2BP2 deficiency need routine endoscopy or repeat H. pylori testing?

No. Endoscopy and repeat testing for H. pylori, a stomach bacterium, are not universal for everyone with this condition; they are generally based on symptoms such as persistent diarrhea, weight loss, or bleeding, as well as anemia, family history, and the clinician’s assessment.

What blood and liver findings should be monitored?

Regular blood counts can look for low red cells or platelets, while liver blood tests assess liver health. Clinicians may also check vitamin B12 and iron, examine for enlarged lymph nodes or a swollen spleen, and consider liver ultrasound or elastography when liver enzymes are elevated.

How can I manage anxiety about scans and repeated appointments?

Scan anxiety and feeling overwhelmed by ongoing care are common with rare chronic conditions. Ask your team about support from a health psychologist or social worker, and discuss a care coordinator or written emergency plan if appointments and communication are difficult to manage.

Get notified when new evidence is published on Common variable immunodeficiency phenotype due to IRF2BP2 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (18)

1
Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review.
Lee EY, Betschel S, Grunebaum E
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):21 doi:10.1186/s13223-022-00661-7.
PMID: 35264237
2
Common variable immunodeficiency.
Solanich X, Antolí A, Alsina L
Medicina clinica 2025; (165(5)):107168 doi:10.1016/j.medcli.2025.107168.
PMID: 41045774
3
State-of-the-art diagnostic evaluation of common variable immunodeficiency.
Lee TK, Gereige JD, Maglione PJ
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2021; (127(1)):19-27 doi:10.1016/j.anai.2021.03.005.
PMID: 33716149
4
Gastrointestinal manifestations of common variable immunodeficiency: what a gastroenterologist needs to be aware of.
Levy DM, Meriwether M, Schwartz MR, et al.
Expert review of gastroenterology & hepatology 2026; (20(8)):673-682 doi:10.1080/17474124.2026.2716136.
PMID: 42557929
5
Clinical practice guideline for the diagnosis of granulomatous-lymphocytic interstitial lung disease in patients with common variable immunodeficiency disorders: an ERS Clinical Research Collaboration.
Bintalib HM, van de Ven AAJM, Rojas-Reyes MX, et al.
The European respiratory journal 2026; (68(3)) doi:10.1183/13993003.02224-2025.
PMID: 42350065
6
Current concepts: Common variable immunodeficiency.
Cunningham-Rundles C
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2026; (136(4)):376-386 doi:10.1016/j.anai.2025.11.009.
PMID: 41274495
7
Lung disease in patients with common variable immunodeficiency.
López AL, Paolini MV, Fernández Romero DS
Allergologia et immunopathologia 2020; (48(6)):720-728 doi:10.1016/j.aller.2020.04.001.
PMID: 32446785
8
Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.
Cabanero-Navalon MD, de Andrés-Martín A, Gil AA, et al.
Frontiers in immunology 2026; (17()):1897051 doi:10.3389/fimmu.2026.1897051.
PMID: 42676356
9
Gastric Cancer Screening in Common Variable Immunodeficiency.
van der Poorten DK, McLeod D, Ahlenstiel G, et al.
Journal of clinical immunology 2018; (38(7)):768-777 doi:10.1007/s10875-018-0546-3.
PMID: 30219982
10
Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease.
Daza-Cajigal V, Segura-Guerrero M, López-Cueto M, et al.
Frontiers in immunology 2023; (14()):1197361 doi:10.3389/fimmu.2023.1197361.
PMID: 37342345
11
Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency.
Crescenzi L, Pecoraro A, Fiorentino A, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019; (51(11)):1599-1603 doi:10.1016/j.dld.2019.05.016.
PMID: 31155490
12
Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry.
Feuille EJ, Anooshiravani N, Sullivan KE, et al.
Journal of clinical immunology 2018; (38(1)):28-34 doi:10.1007/s10875-017-0456-9.
PMID: 29080979
13
Portal hypertension in common variable immunodeficiency disorders - a single center analysis on clinical and immunological parameter in 196 patients.
Hanitsch LG, Steiner S, Schumann M, et al.
Frontiers in immunology 2023; (14()):1268207 doi:10.3389/fimmu.2023.1268207.
PMID: 38187397
14
When immunity turns rogue: lymphoma and lymphoproliferative disorders in common variable immune deficiency.
Sciacca B, Franco M, Gualtiero G, et al.
Current opinion in allergy and clinical immunology 2025; (25(6)):444-454 doi:10.1097/ACI.0000000000001121.
PMID: 41158013
15
A High Prevalence of Gastrointestinal Manifestations in Common Variable Immunodeficiency.
Pikkarainen S, Martelius T, Ristimäki A, et al.
The American journal of gastroenterology 2019; (114(4)):648-655 doi:10.14309/ajg.0000000000000140.
PMID: 30747770
16
PROMIS-29 survey confirms major impact of fatigue on health-related quality of life in common variable immunodeficiency.
Zhang S, Kline M, Fuleihan RL, et al.
Immunologic research 2020; (68(6)):379-388 doi:10.1007/s12026-020-09162-4.
PMID: 33161558
17
Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.
Lawrence MG, Kim VHD, Orange JS, Scherzer R
The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.
PMID: 42447994
18
Immunodeficiency: Burden of Illness.
Hsueh JC, Van Hersh AT, Zhao W
Allergy and asthma proceedings 2024; (45(5)):294-298 doi:10.2500/aap.2024.45.240060.
PMID: 39294910

This page is for informational purposes only and does not constitute medical advice; your immunologist and care team should tailor monitoring to your symptoms, test results, and family history.